Winfried V. Kern

机构：University of Freiburg, University Medical Center Freiburg · ORCID：0000-0003-2550-358X

发表论文 472 篇 · 总被引 20120 次 · h-index 71

代表论文

• Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial (2022 · The Lancet · 被引 184)
• Efficacy and safety of an early oral switch in low-risk Staphylococcus aureus bloodstream infection (SABATO): an international, open-label, parallel-group, randomised, controlled, non-inferiority trial (2024 · The Lancet Infectious Diseases · 被引 95)
• Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study (2025 · PLoS Medicine · 被引 75)
• Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trial (2022 · Nature Cancer · 被引 62)
• Resolving colistin resistance and heteroresistance in Enterobacter species (2023 · Nature Communications · 被引 59)
• Epidemiological trends and susceptibility patterns of bloodstream infections caused by Enterococcus spp. in six German university hospitals: a prospectively evaluated multicentre cohort study from 2016 to 2020 of the R-Net study group (2024 · Infection · 被引 24)